ARGX:NASDAQ
argenx SE - ADR
$970.66
arrow_downward
-0.16%(-1.59) 1D
$970.66
0.00% (0.00)
bedtimeAfter hours
Closed: Sep 29, 4:00:01 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ARGX...
Open
$965.05
High
$974.24
Low
$956.25
Mkt. cap
60.09B
Avg. vol.
273.68K
Volume
0.00
P/E ratio
36.88
52-wk high
$1,072.75
52-wk low
$661.85
EPS
$26.32
Beta
0.47
Shares outstanding
62.56M
No. of employees
2K
Open
$965.05
High
$974.24
Low
$956.25
Mkt. cap
60.09B
Avg. vol.
273.68K
Volume
0.00
P/E ratio
36.88
52-wk high
$1,072.75
52-wk low
$661.85
EPS
$26.32
Beta
0.47
Shares outstanding
62.56M
No. of employees
2K
News stories
From web sources and news partners
AD HOC NEWS
·
13 hours ago
argenx stock after-hours at EUR 850.90: minus 0.58 percent versus prior close
TipRanks
·
16 hours ago
Argenx Unveils New VYVGART and Pipeline Data at AANEM and MGFA
Stock Titan
·
17 hours ago
Treatment data for nerve and muscle conditions is on argenx (ARGX)’s conference agenda.
Profile
Argenx SE is a Belgian-Dutch pharmaceutical company specializing in immunology. Argenx specializes in the development of antibody therapies for the treatment of autoimmune diseases and cancer. Its work primarily focuses on the development of orphan drugs. Wikipedia
About argenx SE - ADR